A think tank for accelerating scientific, technological, and industrial progress
The US is the R&D lab for the world and we should act like it
American science and technology are the best in the world, but they rest on a fragile foundation. Slow productivity growth, sclerotic institutions, and growing international competition have revealed fault lines in our innovation ecosystem. The Institute for Progress (IFP) focuses on pragmatic policy reforms that drive breakthrough discoveries, attract top talent, and expand our nation’s capacity to build.
Metascience
How can we change the incentives within science to produce more breakthrough research?
View all Metascience articles
High-Skilled Immigration
How can we attract and retain superstar talent from around the globe?
View all High-Skilled Immigration articles
Biotechnology
How can we prevent future pandemics and accelerate progress in the life sciences?
View all Biotechnology articles
Infrastructure
How can we make it easier to build things in the world of atoms?
View all Infrastructure articles
Emerging Technology
How can we shape the frontier of technological development and deployment?
View all Emerging Technology articles
Spotlight research
Emerging Technology
Request for Proposals: The Launch Sequence
Apply to our rolling effort to find, scope, and build the most important projects to prepare the world for advanced AI
Read the full report
High-Skilled Immigration
The Cost of the OPT FICA Exemption
How closing a tax exemption can raise tens of billions of dollars
Read the full report
Biotechnology
Protect Human Subjects, Not Bureaucracy
How investigator choice in IRBs can improve ethical oversight
Read the full report
Metascience
How to Accelerate the American Scientific Enterprise
Five recommendations for the Office of Science and Technology Policy's plan to accelerate science
Read the full report
Read more recent publications
Biotechnology
Proxy Praxis: Why Validating an Endpoint Took Twelve Years
Fragmented data and misaligned incentives are blocking faster clinical trials
Read the full report
Biotechnology
Proxy Praxis: How Surrogate Endpoints Can Speed Drug Development
A new series from the Institute for Progress
Read the full report
Emerging Technology
Should the US Sell Hopper Chips to China?
Assessing the impacts of exporting the H200 or H100 AI chips
Read the full report
Metascience
Lab-Directed R&D at the National Labs
Decentralized funding can empower institutions to pursue innovative science
Read the full report
Metascience
How Much Should We Spend on Scientific Replication?
A data-driven framework for targeting replication funding where it matters most
Read the full report
Emerging Technology
Should the US Sell Blackwell Chips to China?
Assessing the impacts of exporting the NVIDIA B30A AI chip
Read the full report
Emerging Technology
How to Implement an Operation Warp Speed for Rare Earths
A coordinated, whole-of-government effort to secure America’s rare earth supply chain
Read the full report
High-Skilled Immigration
The “Wage Level” Mirage
How DHS’s H-1B proposal could help outsourcers and hurt US-trained talent
Read the full report
Emerging Technology
Unlocking a Million Times More Data for AI
How a new ARPANET-style program could solve the data accessibility problem
Read the full report
Metascience
American Science Should Take a Lot More Risks
Scientific efficiency isn’t primarily about the dollars we could save; it’s about the breakthroughs we could be missing
Read the full report
Emerging Technology
Preparing for Launch
An introduction to The Launch Sequence: Why shaping AI progress matters, and how to go about it
Read the full report
Emerging Technology
Teaching AI How Science Actually Works
How block-grant labs can generate the real-world data AI needs to do science
Read the full report
